ArticleJournal for immunotherapy of cancer2025

Correction: Novel post-translational modification learning signature reveals B4GALT2 as an immune exclusion regulator in lung adenocarcinoma.

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.